Patients with SSc have an increased risk of malignancy compared with the general population and these data suggest a high prevalence of papillary TC, in particular in the presence of thyroid autoimmunity. PubMed, Rheumatology (Oxford), 09/30/2015. (Also see Autoimmune Thyroid Diseases and Cancer and Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.